Infection and Immunity, April 2000, p. 1905-1911, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Laboratory of Molecular Parasitology, New York Blood Center, New York, New York,1 and Tropical Medicine Research Station2 and District Referal Hospital,3 Kumba, Cameroon
Received 22 July 1999/Returned for modification 30 September 1999/Accepted 11 January 2000
Antigen-specific interleukin-5 (IL-5), gamma interferon (IFN-
),
and granulocyte-macrophage colony-stimulating factor (GM-CSF) responses
in individuals living in an area of hyperendemicity for onchocerciasis
in Cameroon were examined. The responses against antigens prepared from
Onchocerca volvulus third-stage larvae (L3), molting L3
(mL3), and crude extract from adult males (M-OvAg) were compared to the
responses against antigens from adult female worms and skin
microfilariae. Cytokine responses for the putatively immune individuals
(PI) and the infected individuals (INF) were compared. A differential
cytokine profile of IL-5 (Th2 phenotype) and IFN-
(Th1 phenotype)
was found in these individuals in response to the antigens. In both the
PI and the INF, Th2 responses against all the antigens tested were
dominant. However, in the PI group as a whole, there was an enhanced
Th2 response against the larval antigens and the adult male and adult
female antigens, and a Th1 response in a subgroup of the PI (27 to
54.5%) against L3, mL3, and M-OvAg antigens was present. While the PI
produced significantly higher levels of GM-CSF against L3, mL3, and
M-OvAg antigens than the INF, there was no difference in the GM-CSF
responses of the groups against the other antigens. The present study
indicated that, in comparison to the INF, the PI have distinct
larva-specific and adult male-specific cytokine responses, thus
supporting the premise that immunological studies of the PI would lead
to the identification of immune mechanisms and the target genes that play a role in protective immunity.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|